The patch was finally examined in vivo to investigate possible novel mechanisms for the antimigraine action of ZOL via alternative pathways affecting the altered migraine chronification genes (RAMP-1, and NPTX-2), or microRNAs and modulation of the endocannabinoid; CB-1/MAPK pathway. This evidence concerns the gene CNR1 and migraine disorder.